Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Risk factors for a suboptimal response to gonadotropin-releasing hormone agonist trigger during in vitro fertilization cycles.
Journal: Fertility and sterility
Published: February 18, 2015
Beyond the American Society for Reproductive Medicine transfer guidelines: how many cleavage-stage embryos are safe to transfer in women ≥43 years old?
Journal: Fertility and sterility
Published: February 20, 2014
Diminished ovarian reserve is the predominant risk factor for gonadotropin-releasing hormone antagonist failure resulting in breakthrough luteinizing hormone surges in in vitro fertilization cycles.
Journal: Fertility and sterility
Published: February 20, 2014
In vitro fertilization versus conversion to intrauterine insemination in the setting of three or fewer follicles: how should patients proceed when follicular response falls short of expectation?
Journal: Fertility and sterility
Published: January 11, 2013
Consecutive gonadotropin-releasing hormone-antagonist in vitro fertilization cycles: does the elapsed time interval between successive treatments affect outcomes?
Journal: Fertility and sterility
Published: May 09, 2012
Can in vitro fertilization cycles be salvaged by repeat administration of intramuscular human chorionic gonadotropin the day after failed injection?
Journal: Fertility and sterility
Published: May 09, 2012
Showing 1-6 of 6
Last Updated: 09/26/2026